Global Neisseria Gonorrhoeae Infections Treatment Market Research Report 2019

Table of Contents

Executive Summary

1 Neisseria Gonorrhoeae Infections Treatment Market Overview

• 1.1 Product Overview and Scope of Neisseria Gonorrhoeae Infections Treatment
• 1.2 Neisseria Gonorrhoeae Infections Treatment Segment by Type
  • 1.2.1 Global Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Comparison by Type (2014-2025)
  • 1.2.2 Cribrostatin-6
  • 1.2.3 Dalbavancin
  • 1.2.4 Debio-1453
  • 1.2.5 Gepotidacin Mesylate
  • 1.2.6 Others
• 1.3 Neisseria Gonorrhoeae Infections Treatment Segment by Application
  • 1.3.1 Neisseria Gonorrhoeae Infections Treatment Consumption Comparison by Application (2014-2025)
  • 1.3.2 Clinic
  • 1.3.3 Hospital
  • 1.3.4 Others
• 1.3 Global Neisseria Gonorrhoeae Infections Treatment Market by Region
  • 1.3.1 Global Neisseria Gonorrhoeae Infections Treatment Market Size Region
  • 1.3.2 North America Status and Prospect (2014-2025)
  • 1.3.3 Europe Status and Prospect (2014-2025)
  • 1.3.4 China Status and Prospect (2014-2025)
  • 1.3.5 Japan Status and Prospect (2014-2025)
  • 1.3.6 Southeast Asia Status and Prospect (2014-2025)
  • 1.3.7 India Status and Prospect (2014-2025)
• 1.4 Global Neisseria Gonorrhoeae Infections Treatment Market Size
  • 1.4.1 Global Neisseria Gonorrhoeae Infections Treatment Revenue (2014-2025)
  • 1.4.2 Global Neisseria Gonorrhoeae Infections Treatment Production (2014-2025)

2 Global Neisseria Gonorrhoeae Infections Treatment Market Competition by Manufacturers

• 2.1 Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Manufacturers (2014-2019)
• 2.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Share by Manufacturers (2014-2019)
• 2.3 Global Neisseria Gonorrhoeae Infections Treatment Average Price by Manufacturers (2014-2019)
• 2.4 Manufacturers Neisseria Gonorrhoeae Infections Treatment Production Sites, Area Served, Product Types
• 2.5 Neisseria Gonorrhoeae Infections Treatment Market Competitive Situation and Trends
  • 2.5.1 Neisseria Gonorrhoeae Infections Treatment Market Concentration Rate
  • 2.5.2 Neisseria Gonorrhoeae Infections Treatment Market Share of Top 3 and Top 5 Manufacturers
  • 2.5.3 Mergers & Acquisitions, Expansion

3 Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Regions

• 3.1 Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Regions
• 3.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Regions (2014-2019)
• 3.3 Global Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.4 North America Neisseria Gonorrhoeae Infections Treatment Production
  • 3.4.1 North America Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
  • 3.4.2 North America Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.5 Europe Neisseria Gonorrhoeae Infections Treatment Production
  • 3.5.1 Europe Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
  • 3.5.2 Europe Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.6 China Neisseria Gonorrhoeae Infections Treatment Production (2014-2019)
  • 3.6.1 China Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
  • 3.6.2 China Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
• 3.7 Japan Neisseria Gonorrhoeae Infections Treatment Production (2014-2019)
  • 3.7.1 Japan Neisseria Gonorrhoeae Infections Treatment Production Growth Rate (2014-2019)
  • 3.7.2 Japan Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)

4 Global Neisseria Gonorrhoeae Infections Treatment Consumption by Regions

• 4.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption by Regions
• 4.2 North America Neisseria Gonorrhoeae Infections Treatment Consumption (2014-2019)
• 4.3 Europe Neisseria Gonorrhoeae Infections Treatment Consumption (2014-2019)
• 4.4 China Neisseria Gonorrhoeae Infections Treatment Consumption (2014-2019)
• 4.5 Japan Neisseria Gonorrhoeae Infections Treatment Consumption (2014-2019)

5 Global Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price Trend by Type

• 5.1 Global Neisseria Gonorrhoeae Infections Treatment Production Market Share by Type (2014-2019)
• 5.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue Market Share by Type (2014-2019)
• 5.3 Global Neisseria Gonorrhoeae Infections Treatment Price by Type (2014-2019)
• 5.4 Global Neisseria Gonorrhoeae Infections Treatment Production Growth by Type (2014-2019)

6 Global Neisseria Gonorrhoeae Infections Treatment Market Analysis by Applications

• 6.1 Global Neisseria Gonorrhoeae Infections Treatment Consumption Market Share by Application (2014-2019)
• 6.2 Global Neisseria Gonorrhoeae Infections Treatment Consumption Growth Rate by Application (2014-2019)

7 Company Profiles and Key Figures in Neisseria Gonorrhoeae Infections Treatment Business

• 7.1 Allergan Plc
  • 7.1.1 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.1.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.1.3 Allergan Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.1.4 Main Business and Markets Served
• 7.2 BioDiem Ltd
  • 7.2.1 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.2.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.2.3 BioDiem Ltd Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.2.4 Main Business and Markets Served
• 7.3 Biolytics Pharma
  • 7.3.1 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.3.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.3.3 Biolytics Pharma Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.3.4 Main Business and Markets Served
• 7.4 Debiopharm International SA
  • 7.4.1 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.4.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.4.3 Debiopharm International SA Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.4.4 Main Business and Markets Served
• 7.5 F. Hoffmann-La Roche Ltd.
  • 7.5.1 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.5.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.5.3 F. Hoffmann-La Roche Ltd. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.5.4 Main Business and Markets Served
• 7.6 GlaxoSmithKline Plc
  • 7.6.1 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.6.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.6.3 GlaxoSmithKline Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.6.4 Main Business and Markets Served
• 7.7 Merck & Co., Inc.
  • 7.7.1 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.7.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.7.3 Merck & Co., Inc. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.7.4 Main Business and Markets Served
• 7.8 Paratek Pharmaceuticals, Inc.
  • 7.8.1 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.8.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.8.3 Paratek Pharmaceuticals, Inc. Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.8.4 Main Business and Markets Served
• 7.9 Recce Pty Ltd
  • 7.9.1 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.9.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.9.3 Recce Pty Ltd Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.9.4 Main Business and Markets Served
• 7.10 Redx Pharma Plc
  • 7.10.1 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production Sites and Area Served
  • 7.10.2 Neisseria Gonorrhoeae Infections Treatment Product Introduction, Application and Specification
  • 7.10.3 Redx Pharma Plc Neisseria Gonorrhoeae Infections Treatment Production, Revenue, Price and Gross Margin (2014-2019)
  • 7.10.4 Main Business and Markets Served
• 7.11 Sarepta Therapeutics, Inc.
• 7.12 Sumitomo Dainippon Pharma Co., Ltd.

8 Neisseria Gonorrhoeae Infections Treatment Manufacturing Cost Analysis

• 8.1 Neisseria Gonorrhoeae Infections Treatment Key Raw Materials Analysis
  • 8.1.1 Key Raw Materials
  • 8.1.2 Price Trend of Key Raw Materials
  • 8.1.3 Key Suppliers of Raw Materials
• 8.2 Proportion of Manufacturing Cost Structure
• 8.3 Manufacturing Process Analysis of Neisseria Gonorrhoeae Infections Treatment
• 8.4 Neisseria Gonorrhoeae Infections Treatment Industrial Chain Analysis

9 Marketing Channel, Distributors and Customers

• 9.1 Marketing Channel
  • 9.1.1 Direct Marketing
  • 9.1.2 Indirect Marketing
• 9.2 Neisseria Gonorrhoeae Infections Treatment Distributors List
• 9.3 Neisseria Gonorrhoeae Infections Treatment Customers

10 Market Dynamics

• 10.1 Market Trends
• 10.2 Opportunities
• 10.3 Market Drivers
• 10.4 Challenges
• 10.5 Influence Factors

11 Global Neisseria Gonorrhoeae Infections Treatment Market Forecast

• 11.1 Global Neisseria Gonorrhoeae Infections Treatment Production, Revenue Forecast
  • 11.1.1 Global Neisseria Gonorrhoeae Infections Treatment Production Growth Rate Forecast (2019-2025)
  • 11.1.2 Global Neisseria Gonorrhoeae Infections Treatment Revenue and Growth Rate Forecast (2019-2025)
  • 11.1.3 Global Neisseria Gonorrhoeae Infections Treatment Price and Trend Forecast (2019-2025)
• 11.2 Global Neisseria Gonorrhoeae Infections Treatment Production Forecast by Regions (2019-2025)
  • 11.2.1 North America Neisseria Gonorrhoeae Infections Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.2 Europe Neisseria Gonorrhoeae Infections Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.3 China Neisseria Gonorrhoeae Infections Treatment Production, Revenue Forecast (2019-2025)
  • 11.2.4 Japan Neisseria Gonorrhoeae Infections Treatment Production, Revenue Forecast (2019-2025)
• 11.3 Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast by Regions (2019-2025)
  • 11.3.1 North America Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2019-2025)
  • 11.3.2 Europe Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2019-2025)
  • 11.3.3 China Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2019-2025)
  • 11.3.4 Japan Neisseria Gonorrhoeae Infections Treatment Consumption Forecast (2019-2025)
• 11.4 Global Neisseria Gonorrhoeae Infections Treatment Production, Revenue and Price Forecast by Type (2019-2025)
• 11.5 Global Neisseria Gonorrhoeae Infections Treatment Consumption Forecast by Application (2019-2025)

12 Research Findings and Conclusion

13 Methodology and Data Source

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List